Start
•Completion
Effects of Dimethyltryptamine in Healthy Subjects
CompletedRegisteredCTG
Double-blind, placebo-controlled 5-period crossover HV study (n=31) testing four intravenous DMT infusion schedules (total doses 0, 54, 69, 90, 115 mg) to characterise subjective and autonomic effects.
Details
This randomised, quadruple-blind, five-period crossover study in healthy volunteers compares four intravenous DMT administration schemes and placebo using a bolus and maintenance perfusion model to produce a stable, prolonged DMT experience.
Primary aims are to test dose–response relationships and to compare bolus-plus-perfusion versus perfusion-only schedules on pharmacokinetic, subjective and autonomic outcomes; safety and tolerability are systematically recorded.
Topics:Healthy Volunteers
Registry
Registry linkNCT04353024